AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Near-Infrared Spectroscopy, Acute Taurine Supplementation, and Isolated Muscular Endurance and Fatigue Resistance in Young Healthy Adults

RecruitingNAAges 18 Years - 40 YearsAllLouisiana State University and A&M College
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to determine the association between near-infrared spectroscopy (NIRS)-derived mitochondrial oxidative phosphorylation (OXPHOS) capacity of the vastus lateralis muscles, and both local muscular endurance capacity and local muscular fatigability of the thigh muscles in young adults. Additionally, this trial aims to determine the effect of acute taurine supplementation on local muscular endurance capacity and local muscular fatigability when compared to a placebo condition. The main questions it aims to answer are: 1. Will there be a positive correlation between NIRS rate constant (a marker of mitochondrial function) and local muscular endurance capacity, along with a negative correlation between NIRS rate constant and local muscular fatigability? 2. Will acute taurine supplementation lead to improvements in local muscular endurance capacity and local mu

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Capable and willing to give written informed consent * Capable of understanding inclusion and exclusion criteria * No medical condition that would limit participation in supervised exercise * No current prescription medications known to impact mitochondrial function * Sedentary or recreationally active (self-report average MVPA \< 300 mins/week) * Willing to allow researchers to use data for research purposes Exclusion Criteria: * Self-report history of diabetes mellitus * Self-report history of cardiovascular, peripheral vascular, cerebral vascular, pulmonary, or renal disease * Self-report history of uncontrolled hypertension (resting systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 100 mmHg) * Self-report history of blood clotting disorders * Self-report history of sickle cell trait * Self-report history of myopathy leading to muscle loss, weakness, severe cramps, or myalgia * Self-report history of musculoskeletal disorders * Self-report history of lower limb musculoskeletal injuries that may cause significant differences in the functional capacities of the right and left legs * Self-report history of neurological disorders * Active tobacco, E-cigarette, or nicotine use * Recent (within previous 2 weeks) consumption of energy drinks or supplements containing โ‰ฅ 1 gram of taurine on \> 2 days/week * Actively taking medications to treat blood-clotting disorders * Any condition that, in the judgement of the Principal Investigator, may interfere with study participation and adherence to the protocol * Participants may be excluded if measured adipose tissue thickness is \> 2.0 cm at the site of NIRS assessment or if the accessor is unable to obtain high-quality NIRS signals
๐Ÿ’Š

What it tests

  • Acute Taurine Supplementation
  • Acute Placebo Supplementation
๐Ÿ“

Where

1 site
Huey P. Long Fieldhouse Exercise Physiology Laboratory
Baton Rouge, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy